StartLife’s Post

🌟 We've tracked over 𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐄𝐮𝐫𝐨𝐬 in funding raised by female-led (and female co-led) ventures in #Europe in 2024 - so far. With the arrival of Q2, it's time to recap the raises that came from our community (and beyond) in Q1 from our female-founded #funding list. 👉 Q1s top verticals included: #MedTech, #BioTech, #FinTech & #InsureTech, Enterprise Software, and #ClimateTech 👉 In Q1, around half of the funding from the quarter came from Series B rounds, but #seed funding and Series A funding were almost neck and neck with around 20% of our tracked funding raised. 𝗡𝗼𝘄, 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗮𝘁 𝗠𝗮𝗿𝗰𝗵 - let's congratulate some epic founders who raised! 🙌 💸 Kamila Zahradnickova, Founder & CEO of Lakmoos 💰 Nicola Broughton, Founder & Executive Chair of Wobble Genomics 💸 Claire LAURENT, co-fondatrice & COO of Bene Bono 💰 Aida Lutaj, CEO & Co-Founder of Legitify 💸 Laurie Lancee and Jozien Boersma, Founders of Vini Mini 💰 Suzanne Zamany Andersen, CEO of NitroVolt 💸 Jayne Sibley, CEO and Co-Founder of Sibstar 💰 Bénédicte Tilloy, Co-Founder and General Manager of Ask for the moon 💸 Sònia Hurtado & María Cermeño, Co-Founders of POSEIDONA 💰 Rosalyn Moran, CEO of Stanhope AI 💸 Laetitia Grimaud (Agaesse), Co-Founder & Head of Growth at D2X Group 💰 Zahra Alubudi, COO & Co-Founder at Levenue 💸 Daniela Seixas, FOunder & CEO at Tonic App 💰 Michaela Wachtel, Co-Founder & Partner at watttron 💸 Rachel Mumford, Co-Founder & COO at Anima 💰Olga Chashchina, Co-Founder & Cto at Metyos 💸 Fiona Kelleher, CEO of MyGug 💰 Arelys Sosa, CEO & Co-Founder at DREV 💸 Ulla Saari, Co-Founder at Firecell 👉 ... and more that you can explore on our funding list here: https://lnkd.in/dp-tKwAH Did we miss your raise? Submit it to the list or comment here!

Recent developments in health are pretty exciting, focusing on bridging the gap between treatment and prevention and leveraging AI for automation and early disease detection. For instance, Octopus Investments Ventures highlighted the consumerisation of healthcare and AI-led automation as critical trends. Additionally, Israeli venture capital firm Pitango raised $175 million for a healthcare fund, investing in startups like Nevia Bio for women's health and QuantHealth for AI-led clinical trial simulations. #Healthtech

🚀💚 𝐄𝐯𝐞𝐫 𝐡𝐚𝐝 𝐚𝐧 𝐢𝐝𝐞𝐚 𝐬𝐨 𝐢𝐦𝐩𝐚𝐜𝐭𝐟𝐮𝐥 𝐢𝐭´𝐬 𝐰𝐨𝐫𝐭𝐡 €7 𝐦𝐢𝐥𝐥𝐢𝐨𝐧?  💸 I’m incredibly proud to be part of the #XOLife journey and the visionary idea of Dr. Friderike Bruchmann to revolutionise our #healthcaresystem in Germany. Securing €7 million in funding is not just a milestone for the company, it’s a deeply personal achievement for me as it marks the first time in my career that I’ve had the privilege of managing an A financing round. 𝐁𝐮𝐭 𝐥𝐞𝐭’𝐬 𝐛𝐞 𝐜𝐥𝐞𝐚𝐫 - 𝐭𝐡𝐢𝐬 €7 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐬 𝐣𝐮𝐬𝐭 𝐭𝐡𝐞 𝐛𝐞𝐠𝐢𝐧𝐧𝐢𝐧𝐠! 🚀 For the second time in my still young career, I’m part of a startup that has the potential - and the drive - to 𝐛𝐫𝐞𝐚𝐤 𝐭𝐡𝐞 €100 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐦𝐚𝐫𝐤 within a few years. The energy, the vision, and the relentless pursuit of innovation here at #XOLife are unlike anything I’ve experienced before. 🙏 𝐀 𝐇𝐞𝐚𝐫𝐭𝐟𝐞𝐥𝐭 𝐓𝐡𝐚𝐧𝐤 𝐘𝐨𝐮 To our incredible team - 30 𝐩𝐞𝐨𝐩𝐥𝐞, 13 𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥𝐢𝐭𝐢𝐞𝐬 - this may sound unimaginable to some companies, but for me, it’s the only way to truly innovate and push boundaries. Diversity isn’t just a buzzword; it’s a must-have when you’re working on something with the potential for international success. It’s how “𝐭𝐡𝐢𝐧𝐤𝐢𝐧𝐠 𝐨𝐮𝐭𝐬𝐢𝐝𝐞 𝐭𝐡𝐞 𝐛𝐨𝐱” becomes a reality. 🌍 🌟 𝐀 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐚𝐜𝐤𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐭𝐡𝐞 𝐮𝐧𝐬𝐮𝐧𝐠 𝐡𝐞𝐫𝐨𝐞𝐬 𝐨𝐟 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦, whose commitment, creativity, and positivity behind the scenes drive us forward every single day: Gabriela S., Yasemin Çetik, Avinash N., Hien Nguyen, Sarah Liewehr, Maksym Radishevskyi, Nitish Juttu and Schirin Yazgan! 🔧 𝐌𝐲 𝐍𝐞𝐱𝐭 𝐒𝐭𝐞𝐩𝐬 Now, the real work begins. I’m focused on developing marketing structures that will take the ImpactMonitor™ platform to the next level. From a complete overhaul of our website - aiming to place it in the top 1% of SEO rankings - to creating scalability and driving product development, 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐢𝐬 𝐚𝐥𝐥 𝐚𝐛𝐨𝐮𝐭 𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠, 𝐨𝐩𝐭𝐢𝐦𝐢𝐬𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐞𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠. This journey is just getting started, and I’m thrilled to be part of it. 𝐋𝐞𝐭’𝐬 𝐤𝐞𝐞𝐩 𝐩𝐮𝐬𝐡𝐢𝐧𝐠 𝐛𝐨𝐮𝐧𝐝𝐚𝐫𝐢𝐞𝐬, 𝐬𝐞𝐭𝐭𝐢𝐧𝐠 𝐫𝐞𝐜𝐨𝐫𝐝𝐬, 𝐚𝐧𝐝 𝐦𝐚𝐤𝐢𝐧𝐠 𝐚𝐧 𝐢𝐦𝐩𝐚𝐜𝐭! 😎 #StartupLife #SeriesA #DigitalHealth #ImpactMonitor #InternationalExpansion #MarketingStrategy #SEO #Innovation #HealthcareRevolution #ProudToBePartOfThis

With less than a week until our third annual Cavenagh Health Investor Breakfast, meet some of our distinguished panellists! As we aim to explore answers to the critical question: “From Defense to Offence: Is Now the Time to Shift Investment Strategies?” our panel of industry leaders will discuss strategies to navigate uncertainty in our current high-stakes investment landscape, Our first panellist is Debora Dumont, co-founder and Managing Partner of Bioqube Ventures. With a wealth of experience as a board member across biotech companies and her involvement in numerous international venture capital transactions, Debora brings invaluable insights and expertise across the industry to the panel. Our second panellist is the Managing Partner at Wellington Partners, Regina Hodits. Since joining the industry in 2000, she has become an influential investor in the European VC sector, specialising in early-stage and growth deals within Life Sciences. On the panel, we'll also welcome Ingrid Teigland Akay, MD MBA, Managing Partner at Hadean Ventures, who is also a medical doctor and experienced investment professional with a background in healthcare, consumer goods, and technology. This is set to be a morning packed with insightful discussions on navigating the complexities of today's market. If you’re an investor interested in attending, please contact Stephanie Murtagh for details. #HealthcareInvestment #LifeSciences #InvestmentStrategies #CavenaghHealth #JefferiesHealthcareBreakfast #ImpactInvesting #Biotech

Healthome Closes Seed Funding Round

🎉 Congratulations to Qantev on securing a €30M funding round, led by Blossom Capital, with continued support from other historical investors Elaia and RAISE! 🎉 💡 As proud supporters, we’ve seen Qantev’s impressive growth in helping health and life insurers across 12 countries (from the US to Asia) optimise their claims management processes with their highly advanced AI-driven solutions. Their platform leverages powerful AI to make claims handling faster and more efficient, significantly reducing costs and improving decision-making for insurers worldwide. This latest funding will fuel further advancements in their cutting-edge AI capabilities, drive global expansion, and allow them to attract top-tier talent to keep enhancing their platform. A big congratulations to Tarik Dadi, Hadrien De March, and the entire Qantev team for their dedication and hard work. We’re proud to continue supporting your journey in improving the insurance landscape! Michel de Lempdes Ophelia Brown Anne-Sophie CARRESE Stéphane PESQUE #AI #InsurTech #Qantev #fundraising

In our March meeting of the CEO Connection powered by CEOthreesixty, we had a special guest speaker addressing one of the most important topics facing early-stage Life Sciences CEOs – Capital fundraising and pitching their story. The group's Forum leaders, John Foley and David H. Crean called upon a VC fundraising expert Melanie Platt, Founder of Pitch Hackerz. Having raised more than $500M for early-stage technology and Life Sciences entities, Melanie laid it all out on the table for the CEOs and put to rest many misconceptions about fundraising an pitching to Venture funds in just 20 minutes. Melanie's style is unabashedly direct, honest, authentic, and refreshing. The CEO members and sponsor partners in the room walked away with invaluable insights.    Key Points conveyed by Melanie: ·     "VC’s need to understand what you have in 5 seconds." Convey your needs while ensuring you meet the fit of the VC’s thesis. ·     "VCs need to understand your differentiator - what makes you so special?" If you are building something revolutionary, now is the time to show it. ·     "Don’t ask VCs if you can jump on a quick call." - send them your info and make it easy as possible to say yes to you. ·     Make sure the info you send is easily digestible. ·     Your info needs to showcase "VC scale". Thank you, Mel! A big thanks to our partner sponsors and advisors in the ecosystem including Procopio, Cory, Hargreaves & Savitch LLP, Deloitte, Catalent Pharma Solutions, Sayva Solutions, Ty Summerlin, CFP®, Arrow Up Partners, LLC, and Cardiff Advisory LLC #mentoring #lifesciences #biotechnology #pharmaceuticals #medicaldevices #peeradvisory #venturecapital #capitalraising

Big things ahead! 🥼💫♻️ Amorsui has raised an incredible $3.5 million in seed funding. We are excited to allocate the funds toward accelerating product innovation, expanding our market presence, and developing an AI-integrated net-zero medical supply marketplace ✅ The future is now! Check out the article below from FinSMEs to learn more ⬇️

Forbion Raises Over €2 Billion Across Two New Funds, Bringing Total Assets Under Management to €5 Billion   We are thrilled to announce our largest fundraising to date, securing over €2 billion ($2.2 billion) for two new funds. Forbion Growth Opportunities Fund III closed at €1.2 billion ($1.3 billion), and Forbion Ventures Fund VII raised €890 million ($980 million), bringing our total assets under management to €5 billion ($5.5 billion). This significant fundraising follows a period of outstanding performance, with six recent exits valued at over $1 billion each. Forbion’s continued growth reflects our commitment to supporting and building life sciences companies that drive impactful change across the healthcare landscape. We look forward to leveraging this new capital to continue our mission of impacting the future of medicine. We are grateful for the trust and support from our investors as we work to accelerate innovation in the life sciences sector. Click on the following link to learn more: https://lnkd.in/eUrYVC2k #Forbion #LifeSciences #VentureCapital #Fundraising #HealthcareInnovation #Biotech #GrowthOpportunities #InvestingInInnovation 

Created to help the #lifesciences ecosystem thrive, CEOthreesixty is a moderated peer-to-peer advisory where CEOs in this space collaborate to solve their toughest business challenges. Capital fundraising was discussed most recently - take a look at real-world advisors driving measurable results. #lifesciences  #biotechnology  #pharmaceuticals  #medicaldevice  #peeradvisory  #venturecapital  #capitalraising